MPA: medroxy-progesterone acetate contributes to much poor advice for women.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

1. Then and Now: What We Have Learned From the WHI.The Journal of clinical endocrinology and metabolism · 2026
   Review
2. Progesterone increased β-endorphin innervation of the locus coeruleus, but ovarian steroids had no effect on noradrenergic neurodegeneration.Brain research · 2017
   Article
3. How Studies of the Serotonin System in Macaque Models of Menopause Relate to Alzheimer's Disease1.Journal of Alzheimer's disease : JAD · 2017
   Review
4. Ovarian steroids regulate gene expression related to DNA repair and neurodegenerative diseases in serotonin neurons of macaques.Molecular psychiatry · 2015
   Article

Corrections and comments

• Comment on
  Medroxyprogesterone acetate antagonizes estrogen up-regulation of brain mitochondrial function.2011

Authors and funding

1 author at 1 institution in 1 country.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as